Although we previously reported that Aurora-A could promote HCC chemoresistance by targeting NF-κB signaling, whether Aurora-A promotes HCC radioresistance by activation this signaling is unclear. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.